A randomised, placebo-controlled, Phase II trial of adjuvant Avelumab in patients with stage I-III Merkel cell carcinoma
Primary Sponsor
Melanoma and Skin Cancer Trials Limited (MASC Trials)
Collaborating Groups
TROG Cancer Research
Trial Chairperson
Dr Wen Xu, Princess Alexandra Hospital, QLD
Related Post
October 18, 2022
NINJA Radiation Therapy Trial participant tells his journey to treatment
The journey to becoming the 200th participant for the
September 6, 2022
The gift that kept on giving
The NewyWay Coffee Collaboration Newcastle marketing agency, The Marketing
